Macromolecule adducts, target dose and risk assessment
Ehrenberg, L.; Osterman-Golkar, S.; Törnqvist, M.
Progress in Clinical and Biological Research 209b: 253-260
1986
ISSN/ISBN: 0361-7742 PMID: 3749083 Document Number: 278577
Document emailed within 1 workday
Related Documents
Nedi, T.; Yerdaw, M.; Enquoselassie, F. 2002: Assessment of behavioural risk factors for HIV/AIDS in selected target groups in and around Addis Ababa and Nazareth cities, Ethiopia African Journal of Aids Research: Ajar 1(2): 97-101Chang, L.L.; Chen, F.D.; Chang, P.S.; Liu, C.C.; Lien, H.L. 1995: Assessment of dose and risk to the body following conventional and spiral computed tomography Zhonghua Yi Xue Za Zhi 55(4): 283-289
Lala, A.; Berger, J.S. 2011: Percutaneous coronary intervention for acute coronary syndromes: no difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding Evidence-Based Medicine 16(3): 80-81
Wang, Y.; Liu, M. 2008: Quantitative method of health risk assessment for occupational exposure to benzene based on dose-response models Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 26(2): 77-80
Shumakova, A.A.; Arianova, E.A.; Shipelin, V.A.; Sidorova, I.S.; Selifanov, A.V.; Trushina, É N.; Mustafina, O.K.; Safenkova, I.V.; Gmoshinskiĭ, I.V.; Khotimchenko, S.A.; Tute'ian, V.A. 2014: Toxicological assessment of nanostructured silica. I. Integral indices, adducts of DNA, tissue thiols and apoptosis in liver Voprosy Pitaniia 83(3): 52-62
Whittaker, R.; Bramley, D.; Wells, S.; Stewart, A.; Selak, V.; Furness, S.; Rafter, N.; Roseman, P.; Jackson, R. 2006: Will a web-based cardiovascular disease (CVD) risk assessment programme increase the assessment of CVD risk factors for Maori? New Zealand Medical Journal 119(1238): U2077
Sun, W.; Liu, H.; Zhang, N.; Zhang, A.; Ju, M.; Wang, W.; Shi, F.; Hu, N.; Sun, J.; Bu, H.; Li, C. 2015: Assessment of risk factors for patients with anatomical left ventricular aneurysm post acute ST-elevation myocardial infarction by use of multiple-risk-factor assessment models Zhonghua Xin Xue Guan Bing Za Zhi 43(1): 51-55
Mereu, A.; Sardu, C.; Minerba, L.; Contu, P. 2004: Risk target effect on risk perception in an industrial area Annali di Igiene: Medicina Preventiva e di Comunita 16(4): 541-547
Dybing, E.; Alexander, J. 1995: Target dose markers. Exposure indicators for environmental epidemiological studies Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(10): 1249-1252
Stringer, J.S.A.; Sinkala, M.; Chapman, V.; Acosta, E.P.; Aldrovandi, G.M.; Mudenda, V.; Stout, J.P.; Goldenberg, R.L.; Kumwenda, R.; Vermund, S.H. 2003: Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine Aids 17(11): 1659-1665
Li, J.; Dahmen, U.; Beckebaum, S.; Cicinnati, V.; Valentin-Gamazo, C.; Frilling, A.; Malago, M.; Broelsch, C.E. 2006: Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients European Journal of Medical Research 11(4): 139-145
Dallan, L.A. 1997: A macromolecule capable of modifying CK-MB results Arquivos Brasileiros de Cardiologia 69(4): 293
Joshi, S.R. 2007: Endocannabinoid system--a novel target for cardiometabolic risk Journal of the Association of Physicians of India 55: 439-444
Makowka, L.; Falk, R.E.; Falk, J.A.; Teodorczyk-Injeyan, J.; Nossal, N.A.; Rotstein, L.E. 1981: Elimination of 51Cr-labelled target cells as a method of in vivo assessment of immune reactions Folia Biologica 27(6): 388-403
Shipilova, T.; Pshenichnikov, I.; Karaĭ, D.; Ripul'k, E.; Kaĭk, I. 2013: 24-hour heart rate profile in assessment of target organs in women with arterial hypertension Kardiologiia 53(1): 45-50
Gulde, C.; Voigt, R. 1983: Pharmaceutical and biologic availability of chlorpromazine from macromolecule-containing tablets Die Pharmazie 38(8): 542-546
Hoet, P.; Coene, M.; Cocito, C. 1978: Action of inhibitors of macromolecule formation on duplication and recombination of virus 2C-DNA Archives Internationales de Physiologie et de Biochimie 86(4): 916-917
Colpaert, F.C.; Janssen, P.A. 1982: Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination Archives Internationales de Pharmacodynamie et de Therapie 258(2): 283-299
Needham, L.L. 2000: Exposure assessment: forgotten component of risk assessment Central European Journal of Public Health 8 Suppl: 42-43
Hogaş, M.M.; Serban, I.L.ăc.ăm.; Oprişa, C.; Oleniuc, M.; Hogaş, S.; Popescu, I.R.; Hurjui, L.; Serban, D.N.; Siriopol, D.; Dimitriu, A.G. 2011: Essential hypertension in children--risk factors and target organ damage Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(4): 1024-1029